Ligand validation:1OFE

ONL: 5-OXO-L-NORLEUCINE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1OFE_ONL_A_2511	60%	18%	0.12	0.905	0.83	2.54	-	5	0	0	100%	1
1OFE_ONL_B_2511	43%	21%	0.157	0.881	0.71	2.45	-	3	6	0	100%	1
6GQ3_ONL_A_601	94%	43%	0.058	0.966	0.68	1.39	-	1	0	0	100%	1
3BRM_ONL_A_401	83%	19%	0.073	0.935	2.04	1.36	1	1	3	0	100%	1
2J6H_ONL_B_1609	73%	47%	0.078	0.906	0.87	1.07	-	1	6	0	100%	1
8OXX_ONL_A_508	64%	35%	0.093	0.891	0.76	1.68	-	1	1	0	100%	1
4ZDK_ONL_A_601	45%	42%	0.132	0.861	1.54	0.66	2	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.